切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (06) : 294 -297. doi: 10.3877/cma.j.issn.2095-3216.2015.06.005

所属专题: 文献

专家论坛

肿瘤及重金属相关膜性肾病的诊断与治疗
魏日胞1()   
  1. 1. 100853 解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 出版日期:2015-12-28
  • 通信作者: 魏日胞
  • 基金资助:
    国家自然科学基金(81273968, 81471027); 民政部老龄委专项课题(QLB2014W002); 解放军总医院百项优势项目(YS201408)

Diagnosis and treatment for tumor- and heavy metals-related membranous nephropathy

Ribao Wei1,()   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Published:2015-12-28
  • Corresponding author: Ribao Wei
  • About author:
    Corresponding author: Wei Ribao, Email:
引用本文:

魏日胞. 肿瘤及重金属相关膜性肾病的诊断与治疗[J]. 中华肾病研究电子杂志, 2015, 04(06): 294-297.

Ribao Wei. Diagnosis and treatment for tumor- and heavy metals-related membranous nephropathy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(06): 294-297.

膜性肾病是引起成人肾病综合征最常见的病因之一,按其病因可分为原发性和继发性,其中继发性膜性肾病约占总体膜性肾病的1/3。肿瘤及药物相关膜性肾病又是继发性膜性肾病中有意义、也有一定争议的病因,临床需要关注并加强甄别。虽然目前尚不能够准确区分肿瘤相关性膜性肾病与肿瘤合并特发性膜性肾病,但临床应注意:对于中老年膜性肾病患者,要警惕肿瘤的存在,注意肿瘤的筛检;对于发现肿瘤的患者,应注意监测肾损害指标,及时发现肾脏损害并给予干预治疗;对于中老年膜性肾病肾病综合征患者,在应用激素免疫抑制剂治疗前及治疗过程中,也要注意排除肿瘤的可能性。对于有汞接触史的膜性肾病患者,要注意排除汞中毒相关膜性肾病。

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome (NS) in adults, which can be divided into the primary and secondary types. The secondary MN accounts for about 1/3 of the total MN. Among the secondary MN, the tumors- and drugs-related MN is of significance and controversial, which need to be paid attention to and screened clinically. Although it is hard to differentiate accurately between tumors-related MN and IMN complicated with tumors, the following should be noted: the existence of tumors should not be ignored in middle-elderly patients with MN, which should be screened carefully; if the tumor is found, indexes of early renal damage should be measured for proper diagnosis and necessary interfering treatment; and for nephrotic syndrome in the middle-elderly patients with MN, before and during the application of corticosteroids and immunosuppressants, the possibility of tumors should also be ruled out. For MN patients who have a history of exposure to mercury, attention should be paid to exclude the mercury poisoning-related MN.

1
Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy [J]. Am J Kidney Dis, 1993, 22(1): 5-10.
2
刘芳,付平. 恶性肿瘤肾损害[J]. 中国实用内科杂志,2011, 31(2): 100-102.
3
Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes [J]. Semin Nephrol, 2003, 23(4): 400-405.
4
田茂露,胡章学. 肿瘤相关性膜性肾病[J]. 中国中西医结合肾病杂志,2012,13(5): 451-453.
5
Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy [J]. Nephrol Dial Transplant, 2004, 19(3): 574-579.
6
Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy [J]. Nephrol Dial Transplant, 2012, 27(5): 1931-1937.
7
Beck LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J Med, 2009, 361(1): 11-21.
8
Qin W, Beck LH, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy [J]. J Am Soc Nephrol, 2011, 22(6): 1137-1143.
9
张义德,李世军,刘志红. 恶性肿瘤相关性膜性肾病[J]. 肾脏病与透析肾移植杂志,2008,17(3): 295-300.
10
周薇,张俊霞,徐金升,等. 恶性肿瘤相关性肾病综合征12例临床及病理分析[J]. 疑难病杂志,2013,12(2): 142-143.
11
魏日胞,王远大,荣娜,等. 膜性肾病合并食管癌及多发深静脉血栓一例[J/CD]. 中华肾病研究电子杂志,2013,2(1): 48-50.
12
李嵘,王永星.药物性肾损害[J].世界最新医学信息文摘,2015,15(25): 98.
13
张苏华,刘志红,陈惠萍,等.汞中毒相关性膜性肾病[J].肾脏病与透析肾移植杂志,2008,17(4): 318-324.
14
罗婷,魏日胞,贾楠,等.汞中毒相关膜性肾病的临床治疗并文献复习[J].中国药物应用与监测,2013,10(6): 355-358.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[3] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[8] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[9] 李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[10] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[11] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[12] 曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[13] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[14] 徐军, 姬园园, 陈君平, 王健. 伴菊形团结构的脑膜瘤合并颅骨侵犯一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 916-919.
[15] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
阅读次数
全文


摘要